β¨ Health Notices
NEW ZEALAND GAZETTE
No. 42
Health
Michael James Butler
James William Stinear
Shaaron Anne Elmslie
Chiropractors Act 1982
Membership of Chiropractic Board
Pursuant to section 3 of the Chiropractors Act 1982, I hereby reappoint
Meyrick Bruce Adam
Sandra Mary Moran
as members of the Chiropractic Board for a term of office expiring on 13 December 1995, and appoint
as members of the Chiropractic Board for a term of office expiring on 15 May 1997.
Dated at Wellington this 28th day of April 1994.
KATHERINE O'REGAN, Associate Minister of Health.
go3266
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Atenolol 50 mg, 100 mg | Tablets | Douglas Pharmaceuticals Limited, Technical Division, Mount Roskill, Auckland | Anselol |
| Oxymetazoline hydrochloride 0.05% w/v | Nasal spray | Wellcome Australia Limited, Cabarita, New South Wales, Australia | Sudafed Nasal Spray |
| Carvedilol 25 mg | Tablet | Boehringer Mannheim GmbH, Mannheim, Berlin, Germany | Dilatrend |
| Chlorpheniramine maleate 2 mg, paracetamol 300 mg, pseudoephedrine hydrochloride 30 mg | Capsule | Upjohn Pty Limited, Rydalmere, Sydney, Australia | Orthoxicol 3 Sinus Relief |
Dated this 1st day of May 1994.
A. DIXON, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go3263
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Recombinant human deoxyribonuclease 1 mg/ml | Solution for inhalation | Genentech Inc., South San Francisco, California, United States of America | Pulmozyme |
Note: Restricted to specialists experienced in the treatment of cystic fibrosis.
Dated this 27th day of April 1994.
A. DIXON, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go3264
Consent to the Distribution of Changed Medicines
Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Urofollitropin 75 iu | Lyophilised powder for reconstitution | Organon International BV, Oss, The Netherlands and Organon SA, Usine St Charles, Eragny-Sur-Epte, Serifontaine, France | Puregon injection |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1994, No 42
NZLII —
NZ Gazette 1994, No 42
β¨ LLM interpretation of page content
π₯ Chiropractic Board Membership Appointments
π₯ Health & Social Welfare28 April 1994
Chiropractic Board, Appointments, Chiropractors Act 1982
- Meyrick Bruce Adam, Reappointed to Chiropractic Board
- Sandra Mary Moran, Reappointed to Chiropractic Board
- Katherine O'Regan, Associate Minister of Health
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare1 May 1994
Medicines Act 1981, New Medicines, Consent to Distribution
- A. Dixon, Acting Director-General of Health
π₯ Provisional Consent to Distribution of New Medicine
π₯ Health & Social Welfare27 April 1994
Medicines Act 1981, New Medicine, Provisional Consent
- A. Dixon, Acting Director-General of Health
π₯ Consent to Distribution of Changed Medicines
π₯ Health & Social Welfare1 May 1994
Medicines Act 1981, Changed Medicines, Consent to Distribution
- A. Dixon, Acting Director-General of Health